The value of surrogate markers to monitor cholesterol absorption, synthesis and bioconversion to bile acids under lipid lowering therapies

Journal of Steroid Biochemistry and Molecular Biology

Volumn 169, Issue , 2017, Pages 111-122

  Stellaard, Frans ^a   von Bergmann, Klaus ^a   Sudhop, Thomas ^a   Lütjohann, Dieter ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Bile acid precursors; Cholesterol precursors; Fecal balance; Non cholesterol sterols; Oxysterols

Indexed keywords

ANTILIPEMIC AGENT; BILE ACID; CHOLESTEROL; EZETIMIBE; LATHOSTEROL; SIMVASTATIN; 27-HYDROXYCHOLESTEROL; AZETIDINE DERIVATIVE; BIOLOGICAL MARKER; CAMPESTEROL; CHOLEST-5-EN-3 BETA,7 ALPHA-DIOL; CHOLESTEROL DERIVATIVE; PHYTOSTEROL;

ABSORPTION; ARTICLE; BIOTRANSFORMATION; CALCULATION; CATABOLISM; CHOLESTEROL INTAKE; CHOLESTEROL SYNTHESIS; CLINICAL ARTICLE; DISEASE MARKER; HUMAN; MALE; OMNIVORE; PATIENT MONITORING; SENSITIVITY ANALYSIS; SYNTHESIS; VALIDITY; ADULT; ANALOGS AND DERIVATIVES; COMBINATION DRUG THERAPY; FECES; FEMALE; LIPID METABOLISM; METABOLISM; MIDDLE AGED; REPRODUCIBILITY; RETROSPECTIVE STUDY; UPREGULATION; VEGAN DIET;

ADULT; AZETIDINES; BILE ACIDS AND SALTS; BIOMARKERS; CHOLESTEROL; DIET, VEGAN; DRUG THERAPY, COMBINATION; FECES; FEMALE; HUMANS; HYDROXYCHOLESTEROLS; HYPOLIPIDEMIC AGENTS; LIPID METABOLISM; MALE; MIDDLE AGED; PHYTOSTEROLS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SIMVASTATIN; UP-REGULATION;

EID: 84963966361     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2016.03.030     Document Type: Article

References (52)

1. [1] Hofmann, A.F., Biliary secretion and excretion in health and disease: current concepts. Ann. Hepatol. 6:1 (2007), 15–27.
2. [2] Li, T., Chiang, J.Y., Bile acids as metabolic regulators. Curr. Opin. Gastroenterol. 31:2 (2015), 159–165.
3. [3] Trauner, M., Claudel, T., Fickert, P., Moustafa, T., Wagner, M., Bile acids as regulators of hepatic lipid and glucose metabolism. Dig. Dis. 28:1 (2010), 220–224.
4. [4] Kern, F. Jr., Normal plasma cholesterol in an 88-year-old man who eats 25 eggs a day. Mechanisms of adaptation. N. Engl. J. Med. 324:13 (1991), 896–899.
5. [5] Grundy, S.M., Ahrens, E.H. Jr, Measurements of cholesterol turnover, synthesis, and absorption in man, carried out by isotope kinetic and sterol balance methods. J. Lipid Res. 10:1 (1969), 91–107.
6. [6] Crouse, J.R., Grundy, S.M., Evaluation of a continuous isotope feeding method for measurement of cholesterol absorption in man. J. Lipid Res. 19:8 (1978), 967–971.
7. [7] Lütjohann, D., Meese, C.O., Crouse, J.R. 3rd, von Bergmann, K., Evaluation of deuterated cholesterol and deuterated sitostanol for measurement of cholesterol absorption in humans. J. Lipid Res. 34:6 (1993), 1039–1046.
8. [8] Samuel, P., Crouse, J.R., Ahrens, E.H. Jr., Evaluation of an isotope ratio method for measurement of cholesterol absorption in man. J. Lipid Res. 19:1 (1978), 82–93.
9. [9] Bosner, M.S., Ostlund, R.E. Jr, Osofisan, O., Grosklos, J., Fritschle, C., Lange, L.G., Assessment of percent cholesterol absorption in humans with stable isotopes. J. Lipid Res. 34:6 (1993), 1047–1053.
10. [10] Stellaard, F., Lütjohann, D., Fractional cholesterol absorption measurements in humans: determinants of the blood-based dual stable isotope tracer technique. J. Clin. Lipidol. 9:1 (2015), 14–25.
11. [11] Di Buono, M., Jones, P.J., Beaumier, L., Wykes, L.J., Comparison of deuterium incorporation and mass isotopomer distribution analysis for measurement of human cholesterol biosynthesis. J. Lipid Res. 41:9 (2000), 1516–1523.
12. [12] Neese, R.A., Faix, D., Kletke, C., Wu, K., Wang, A.C., Shackleton, C.H., Hellerstein, M.K., Measurement of endogenous synthesis of plasma cholesterol in rats and humans using MIDA. Am. J. Physiol. 264 (1993), E136–47.
13. [13] Jones, P.J., Use of deuterated water for measurement of short-term cholesterol synthesis in humans. Can. J. Physiol. Pharmacol. 68:7 (1990), 955–959.
14. [14] Jones, P.J., Leitch, C.A., Li, Z.C., Connor, W.E., Human cholesterol synthesis measurement using deuterated water: theoretical and procedural considerations. Arterioscler. Thromb. 13:2 (1993), 247–253.
15. [15] Stellaard, F., Sackmann, M., Sauerbruch, T., Paumgartner, G., Simultaneous determination of cholic acid and chenodeoxycholic acid pool sizes and fractional turnover rates in human serum using 13 C-labeled bile acids. J. Lipid Res. 25:12 (1984), 1313–1319.
16. [16] Hulzebos, C.V., Renfurm, L., Bandsma, R.H., Verkade, H.J., Boer, T., Boverhof, R., Tanaka, H., Mierau, I., Sauer, P.J., Kuipers, F., Stellaard, F., Measurement of parameters of cholic acid kinetics in plasma using a microscale stable isotope dilution technique: application to rodents and humans. J. Lipid Res. 42:11 (2001), 1923–1929.
17. [17] Stellaard, F., Brufau, G., Boverhof, R., Jonkers, E.Z., Boer, T., Kuipers, F., Developments in bile acid kinetic measurements using (13)C and (2)H: 10(5) times improved sensitivity during the last 40 years. Isotopes Environ. Health Stud. 45:4 (2009), 275–288.
18. [18] Subbiah, M.T., Tyler, N.E., Buscaglia, M.D., Marai, L., Estimation of bile acid excretion in man: comparison of isotopic turnover and fecal excretion methods. J. Lipid Res. 17:1 (1976), 78–84.
19. [19] Hegele, R.A., Robinson, J.F., ABC transporters and sterol absorption. Curr. Drug Targets Cardiovasc. Haematol. Disord. 5:1 (2005), 31–37.
20. [20] Tilvis, R.S., Miettinen, T.A., Serum plant sterols and their relation to cholesterol absorption. Am. J. Clin. Nutr. 43:1 (1986), 92–97.
21. [21] Miettinen, T.A., Tilvis, R.S., Kesäniemi, Y.A., Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am. J. Epidemiol. 131:1 (1990), 20–31.
22. [22] Simonen, P., Gylling, H., Miettinen, T.A., The validity of serum squalene and non-cholesterol sterols as surrogate markers of cholesterol synthesis and absorption in type 2 diabetes. Atherosclerosis 197:2 (2008), 883–888.
23. [23] Miettinen, T.A., Gylling, H., Nissinen, M.J., The role of serum non-cholesterol sterols as surrogate markers of absolute cholesterol synthesis and absorption. Nutr. Metab. Cardiovasc. Dis. 21:10 (2011), 765–769.
24. [24] Gylling, H., Clinical utility of serum markers of cholesterol absorption and synthesis. Curr. Opin. Lipidol. 25:3 (2014), 207–212.
25. [25] Miettinen, T.A., Tilvis, R.S., Kesäniemi, Y.A., Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged men. Metabolism 38:2 (1989), 136–140.
26. [26] Kempen, H.J., Glatz, J.F., Gevers Leuven, J.A., van der Voort, H.A., Katan, M.B., Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. J. Lipid Res. 29:9 (1988), 1149–1155.
27. [27] Gälman, C., Arvidsson, I., Angelin, B., Rudling, M., Monitoring hepatic cholesterol 7 alpha-hydroxylase activity by assay of the stable bile acid intermediate 7 alpha-hydroxy-4-cholesten-3-one in peripheral blood. J. Lipid Res. 44:4 (2003), 859–866.
28. [28] Hahn, C., von Bergmann, K., Relationship between the serum concentration of 7 alpha-hydroxycholesterol and fecal bile acid excretion in humans. Scand. J. Gastroenterol. 31:8 (1996), 804–808.
29. [29] Oda, H., Yamashita, H., Kosahara, K., Kuroki, S., Nakayama, F., Esterified and total 7 alpha-hydroxycholesterol in human serum as an indicator for hepatic bile acid synthesis. J. Lipid Res. 31:12 (1990), 2209–2218.
30. [30] Sauter, G., Berr, F., Beuers, U., Fischer, S., Paumgartner, G., Serum concentrations of 7 alpha-hydroxy-4-cholesten-3-one reflect bile acid synthesis in humans. Hepatology 24:1 (1996), 123–126.
31. [31] Nissinen, M.J., Gylling, H., Miettinen, T.A., Responses of surrogate markers of cholesterol absorption and synthesis to changes in cholesterol metabolism during various amounts of fat and cholesterol feeding among healthy men. Br. J. Nutr. 99:2 (2008), 370–378.
32. [32] Bosner, M.S., Lange, L.G., Stenson, W.F., Ostlund, R.E. Jr., Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry. J. Lipid Res. 40:2 (1999), 302–308.
33. [33] Jakulj, L., Mohammed, H., van Dijk, T.H., Boer, T., Turner, S., Groen, A.K., Vissers, M.N., Stroes, E.S., Plasma plant sterols serve as poor markers of cholesterol absorption in man. J. Lipid Res. 54:4 (2013), 1144–1150.
34. [34] Jakulj, L., Vissers, M.N., Groen, A.K., Hutten, B.A., Lutjohann, D., Veltri, E.P., Kastelein, J.J., Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial. J. Lipid Res. 51:4 (2010), 755–762.
35. [35] Kasmas, S.H., Izar, M.C., França, C.N., Ramos, S.C., Moreira, F.T., Helfenstein, T., Moreno, R.A., Borges, N.C., Figueiredo-Neto, A.M., Fonseca, F.A., Differences in synthesis and absorption of cholesterol of two effective lipid-lowering therapies. Braz. J. Med. Biol. Res. 45:11 (2012), 1095–1101.
36. [36] Thongtang, N., Lin, J., Schaefer, E.J., Lowe, R.S., Tomassini, J.E., Shah, A.K., Tershakovec, A.M., Effects of ezetimibe added to statin therapy on markers of cholesterol absorption and synthesis and LDL-c lowering in hyperlipidemic patients. Atherosclerosis 225:2 (2012), 388–396.
37. [37] Hiramitsu, S., Ishiguro, Y., Matsuyama, H., Yamada, K., Kato, K., Noba, M., Uemura, A., Yoshida, S., Matsubara, Y., Kani, A., Hasegawa, K., Hishida, H., Ozaki, Y., The effects of ezetimibe on surrogate markers of cholesterol absorption and synthesis in Japanese patients with dyslipidemia. J. Atheroscler. Thromb. 17:1 (2010), 106–114.
38. [38] Lakoski, S.G., Xu, F., Vega, G.L., Grundy, S.M., Chandalia, M., Lam, C., Lowe, R.S., Stepanavage, M.E., Musliner, T.A., Cohen, J.C., Hobbs, H.H., Indices of cholesterol metabolism and relative responsiveness to ezetimibe and simvastatin. J. Clin. Endocrinol. Metab. 95:2 (2010), 800–809.
39. [39] Sudhop, T., Lütjohann, D., Kodal, A., Igel, M., Tribble, D.L., Shah, S., Perevozskaya, I., von Bergmann, K., Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation 106:15 (2002), 1943–1948.
40. [40] Sudhop, T., Reber, M., Tribble, D., Sapre, A., Taggart, W., Gibbons, P., Musliner, T., von Bergmann, K., Lütjohann, D., Changes in cholesterol absorption and cholesterol synthesis caused by ezetimibe and/or simvastatin in men. J. Lipid Res. 50:10 (2009), 2117–2123.
41. [41] Clarenbach, J.J., Reber, M., Lütjohann, D., von Bergmann, K., Sudhop, T., The lipid-lowering effect of ezetimibe in pure vegetarians. J. Lipid Res. 47:12 (2006), 2820–2824.
42. [42] Lütjohann, D., Brzezinka, A., Barth, E., Abramowski, D., Staufenbiel, M., von Bergmann, K., Beyreuther, K., Multhaup, G., Bayer, T.A., Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain. J. Lipid Res. 43:7 (2002), 1078–1085.
43. [43] Lütjohann, D., Methodological aspects of plant sterol and stanol measurement. J. AOAC Int. 98:3 (2015), 674–676.
44. [44] Czubayko, F., Beumers, B., Lammsfuss, S., Lütjohann, D., von Bergmann, K., A simplified micro-method for quantification of fecal excretion of neutral and acidic sterols for outpatient studies in humans. J. Lipid Res. 32:11 (1991), 1861–1867.
45. [45] Kempen, H.J., de Knijff, P., Boomsma, D.I., van der Voort, H.A., Gevers Leuven, J.A., Havekes, L., Plasma levels of lathosterol and phytosterols in relation to age, sex, anthropometric parameters, plasma lipids, and apolipoprotein E phenotype, in 160 Dutch families. Metabolism 40:6 (1991), 604–611.
46. [46] Gälman, C., Angelin, B., Rudling, M., Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19. J. Intern. Med. 270:6 (2011), 580–588.
47. [47] Andrade, I., Santos, L., Ramos, F., Cholesterol absorption and synthesis markers in Portuguese hypercholesterolemic adults: a cross-sectional study. Eur. J. Intern. Med. 28 (2016), 85–90.
48. [48] Sauter, G.H., Münzing, W., von Ritter, C., Paumgartner, G., Bile acid malabsorption as a cause of chronic diarrhea: diagnostic value of 7 alpha-hydroxy-4-cholesten-3-one in serum. Dig. Dis. Sci. 44:1 (1999), 14–19.
49. [49] Ellegård, L., Andersson, H., Oat bran rapidly increases bile acid excretion and bile acid synthesis: an ileostomy study. Eur. J. Clin. Nutr. 61:8 (2007), 938–945.
50. [50] Telford, D.E., Sutherland, B.G., Edwards, J.Y., Andrews, J.D., Barrett, P.H., Huff, M.W., The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin. J. Lipid Res. 48:3 (2007), 699–708.
51. [51] Gouni-Berthold, I., Berthold, H.K., Gylling, H., Hallikainen, M., Giannakidou, E., Stier, S., Ko, Y., Patel, D., Soutar, A.K., Seedorf, U., Mantzoros, C.S., Plat, J., Krone, W., Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-coA reductase gene expression: a randomized trial in healthy men. Atherosclerosis 198:1 (2008), 198–207.
52. [52] Engelking, L.J., McFarlane, M.R., Li, C.K., Liang, G., Blockade of cholesterol absorption by ezetimibe reveals a complex homeostatic network in enterocytes. J. Lipid Res. 53:7 (2012), 1359–1368.